Efficacy of HA Gel Injection Versus Multilayer (L-PRF) in the Interdental Papilla Reconstruction

Sponsor
Aya Elleithy (Other)
Overall Status
Completed
CT.gov ID
NCT05953896
Collaborator
(none)
20
1
2
9.1
2.2

Study Details

Study Description

Brief Summary

This research aims to investigate the effectiveness of non invasive application Hyaluronic acid gel injection versus minimally invasive surgical approach using multilayer L-PRF both clinically and radiographically as a suitable treatment modality for interdental papillary deficiency.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Hyaluronic acid gel
  • Combination Product: Multilayer L-PRF membranes
N/A

Detailed Description

A total of 20 patients recruited from the outpatient clinic of Oral Medicine, Periodontology and Oral Diagnosis department, Faculty of Dentistry, Ain-Shams University and seeking treatment for black triangles for esthetic reason. Patients meeting the eligibility criteria are equally and randomly allocated in two different groups. group one Included 10 patients who received interdental papillary reconstruction using multiple layers of L-PRF. Group two Included 10 patients who received interdental papillary reconstruction using Hyaluronic acid gel injection. In the follow-up phase, patients were recalled after 3 and 6 months from intervention where clinical re-measurement of the black triangles and standardized digital clinical photographs and radiographs are done. Black triangle height and surface area was measured and other clinical parameters (Modified papillary bleeding index, Gingival index, clinical attachment level and periodontal probing depth) were assessed at baseline, 3 months and 6 months periods. patient satisfaction was evaluated using the patient satisfaction questionnaire (PSQ-18, short form) at baseline. pain and discomfort was evaluated using Numerical rating scale (NRS) at baseline, 3 months and 6 months periods. Global esthetic improvement scale (GAIS) was evaluated at 3 months and 6 months periods.

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
this study is designed as a parallel randomized controlled clinical trialthis study is designed as a parallel randomized controlled clinical trial
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Efficacy of Hyaluronic Acid Gel Injection Versus Multilayer Leukocyte Platelet Rich Fibrin (L-PRF) in The Interdental Papilla Reconstruction: A Randomized Controlled Clinical Trial
Actual Study Start Date :
Jan 10, 2022
Actual Primary Completion Date :
Jul 10, 2022
Actual Study Completion Date :
Oct 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hyaluronic acid gel

will include 10 patients undergoing non invasive reconstruction of interdental papilla using injectable Hyaluronic acid gel

Combination Product: Hyaluronic acid gel
For the Hyaluronic acid gel group: HA gel was injected 2-3mm apical to the coronal tip of the involved papillae and the needle was directed coronally with an angulation of 45° to the long axis of the tooth, and the bevel directed apically until papilla became blanched. The injection was given at each papilla at the following intervals baseline, one week and two weeks.
Other Names:
  • HA gel
  • Active Comparator: Multilayer L-PRF

    will include 10 patients undergoing minimally invasive surgery for reconstruction of interdental papilla using multilayer L-PRF membranes

    Combination Product: Multilayer L-PRF membranes
    For the multilayer L-PRF group: A single semilunar incision is made in the buccal vestibule, apical to the muco-gingival junction in the mid interproximal area of the papilla to be treated.Tunneling of the incisions has maintained the full height and thickness of the gingiva. Multilayer L-PRF membranes were prepared according to Pinto's protocol immediately prior to the surgery and placed in the tunnel then incision was closed with simple interrupted sutures.

    Outcome Measures

    Primary Outcome Measures

    1. The gingival black triangle height [six months]

      to evaluate the influence of hyaluronic acid gel injection versus multilayer L-PRF on the height of black triangle

    Secondary Outcome Measures

    1. Assessment pf patient satisfaction using Patient Satisfaction Questionnaire [patients scores are evaluated at baseline immediately after the procedure]

      evaluation of patient satisfaction using patient Satisfaction questionnaire (PSQ-18, short form), patients are informed to fill and sign the questionnaire with 18 questions to evaluate their satisfaction of the recieved intervention

    2. Post operative pain assessment using Numerical Pain Rating Scale [six months]

      To evaluate patient's perception of postoperative pain during the treatment time using the NRS (Numeric Pain Rating Scale). The NRS is an 11-point numeric scale that ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")

    3. Assessment of esthetic appearance using the GAIS (global esthetic improvement scale) [six months]

      patients satisfaction of their esthetic appearance will be rocorded using the global esthetic improvement scale with ranges (1: worsened) (2: unchanged) (3: improved) (4: much improved)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. Both genders aged from 18-45 years.

    2. Systemically healthy patients.

    3. Patients with IDP loss class I or II of esthetic zone in upper and lower anterior and premolar teeth according to Nordland and Tarnow's classification (Class I: Presence of the tip of the papilla between interdental contact point and the interproximal CEJ)

    4. Presence of sufficient interdental alveolar bone (i.e. the vertical distance from the interdental contact point to the crest of the interdental bone is ≥ 5 mm) that was confirmed clinically by bone sounding.

    5. A band of keratinized tissue should be present around the test teeth ≥ 2 mm

    6. Periodontal phenotype of the area to be treated is ≥ 2 mm in thickness. Surgical reconstruction of IDP is influenced by gingival tissue phenotype, outcome of papilla reconstruction is better in cases with a thick gingival unit

    7. Patients with good oral hygiene and caring about esthetics and concerned to go through the management of "black triangles" by interdental papillae reconstruction in esthetic zone.

    Exclusion criteria:
    1. Teeth with acute periapical pathosis.

    2. Patients with poor oral hygiene, incompliance to treatment and persistence of gingival inflammation after phase I therapy.

    3. Pregnant and lactating females.

    4. Patients having para-functional habits or local causes as, malocclusion, interdental spacing, rotation, inclination or crowding.

    5. Smokers, alcoholics or drug abusers.

    6. Vulnerable group of patients, orphans, handicapped, prisoners or mentally retarded patients.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 faculty of Dentistry. Ain Shams University Cairo Egypt

    Sponsors and Collaborators

    • Aya Elleithy

    Investigators

    • Principal Investigator: Aya Alleithy, teaching assistant, Teaching assistant at Department of Oral medicine, Periodontology, and Oral Diagnosis, Faculty of Dentistry, A
    • Study Director: Hala Abu El-Ela, proffessor, Professor of Oral Medicine, Periodontology and Oral Diagnosis , Faculty of Dentistry-Ain Shams University & Misr International university
    • Study Director: Susan Sarhan, lecturer, Lecturer of Oral Medicine and Periodontology and Oral diagnosis, Faculty of Dentistry, Ain Shams University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Aya Elleithy, principal investigator, Ain Shams University
    ClinicalTrials.gov Identifier:
    NCT05953896
    Other Study ID Numbers:
    • FDASU-REC 012112
    First Posted:
    Jul 20, 2023
    Last Update Posted:
    Jul 20, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Aya Elleithy, principal investigator, Ain Shams University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 20, 2023